Skip to main content
Erschienen in: Clinical & Experimental Metastasis 7/2011

01.10.2011 | Research Paper

Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma

verfasst von: Yunhong Xia, Rongxin Chen, Sheng-Long Ye, Ruixia Sun, Jun Chen, Yan Zhao

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

The stroma of hepatocellular carcinoma (HCC) is markedly infiltrated with activated hepatic stellate cells (HSCs), and associated invasion and metastasis of HCC. However, little is known of the role of HSCs in immune responses in HCC. The Buffalo rat HCC model was established. Quiescent HSCs (qHSCs) and intratumoral HSCs (tHSCs) were isolated. Surface molecules of tHSC were detected by flow cytometry, and gene expression was analyzed by fluorescence quantitative RT-PCR. T cell proliferation was monitored by [3H]-thymidine (3H-TdR) incorporation into DNA, and cytotoxic activity was assessed by measuring the release of 51Cr. The level of cytokine expression by T cells was measured by enzyme-linked immunosorbent assay. T cell apoptosis was detected by double-stained terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) and anti-CD3 antibodies. The migration and invasion of HCC was observed by transwell experiments. tHSCs express low levels of major histocompatibility complex (MHC) class I, MHC class II, and costimulatory molecules, and produce varying levels of cytokines. Addition of the tHSCs suppressed thymidine uptake by T cells that were stimulated by alloantigens or by anti-CD3-mediated T-cell receptor ligation. The tHSC-induced T-cell hyporesponsiveness was associated with enhanced T-cell apoptosis, and contributed to the migration and invasion of hepatoma cell. tHSCs was associated with markedly enhanced expression of B7-H1. Blockade of B7-H1/PD-1 ligation significantly reduced HSC immunomodulatory activity, and hepatoma cell migration and invasion. tHSCs can induce T cell apoptosis, suggesting an important role for B7-H1. The interactions between tHSCs and T cells may contribute to hepatic immune tolerance and invasion and migration of HCC.
Literatur
1.
Zurück zum Zitat Gressner AM, Weiskirchen R, Breitkopf K et al (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7:d793–d807PubMedCrossRef Gressner AM, Weiskirchen R, Breitkopf K et al (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7:d793–d807PubMedCrossRef
2.
Zurück zum Zitat Svegliati-Baroni G, De Minicis S, Marzioni M (2008) Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int 28:1052–1064PubMedCrossRef Svegliati-Baroni G, De Minicis S, Marzioni M (2008) Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int 28:1052–1064PubMedCrossRef
3.
Zurück zum Zitat Marra F, DeFranco R, Grappone C et al (1999) Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med 47:66–75PubMed Marra F, DeFranco R, Grappone C et al (1999) Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med 47:66–75PubMed
4.
Zurück zum Zitat Lu L, Qian S, Hershberger PA et al (1997) Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 158:5676–5684PubMed Lu L, Qian S, Hershberger PA et al (1997) Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 158:5676–5684PubMed
5.
Zurück zum Zitat Lu L, Woo J, Rao AS et al (1994) Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 179:1823–1834PubMedCrossRef Lu L, Woo J, Rao AS et al (1994) Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 179:1823–1834PubMedCrossRef
6.
Zurück zum Zitat Friedman SL (1993) Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328:1828–1835PubMedCrossRef Friedman SL (1993) Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328:1828–1835PubMedCrossRef
7.
Zurück zum Zitat Kobayashi S, Seki S, Kawada N et al (2003) Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells. Cell Tissue Res 311:353–364PubMed Kobayashi S, Seki S, Kawada N et al (2003) Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells. Cell Tissue Res 311:353–364PubMed
8.
Zurück zum Zitat Yu MC, Chen CH, Liang X et al (2004) Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40:1312–1321PubMedCrossRef Yu MC, Chen CH, Liang X et al (2004) Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40:1312–1321PubMedCrossRef
9.
Zurück zum Zitat Chen CH, Kuo LM, Chang Y et al (2006) In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44:1171–1181PubMedCrossRef Chen CH, Kuo LM, Chang Y et al (2006) In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 44:1171–1181PubMedCrossRef
10.
Zurück zum Zitat Cabrera R, Ararat M, Cao M et al (2010) Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25). Dig Dis Sci 55:484–495PubMedCrossRef Cabrera R, Ararat M, Cao M et al (2010) Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25). Dig Dis Sci 55:484–495PubMedCrossRef
11.
Zurück zum Zitat Kuang DM, Zhao Q, Peng C et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 206:1327–1337PubMedCrossRef Kuang DM, Zhao Q, Peng C et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 206:1327–1337PubMedCrossRef
12.
Zurück zum Zitat Terada T, Makimoto K, Terayama N et al (1996) Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 24:706–712PubMedCrossRef Terada T, Makimoto K, Terayama N et al (1996) Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. J Hepatol 24:706–712PubMedCrossRef
13.
Zurück zum Zitat Aishima S, Nishihara Y, Iguchi T et al (2008) Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol 21:256–264PubMedCrossRef Aishima S, Nishihara Y, Iguchi T et al (2008) Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol 21:256–264PubMedCrossRef
14.
Zurück zum Zitat Desmoulière A, Guyot C, Gabbiani G (2004) The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48:509–517PubMedCrossRef Desmoulière A, Guyot C, Gabbiani G (2004) The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48:509–517PubMedCrossRef
15.
Zurück zum Zitat Yang R, Rescorla FJ, Reilly CR et al (1992) A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 52:193–198PubMedCrossRef Yang R, Rescorla FJ, Reilly CR et al (1992) A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 52:193–198PubMedCrossRef
16.
Zurück zum Zitat Kristensen DB, Kawada N, Imamura K et al (2000) Proteome analysis of rat hepatic stellate cells. Hepatology 32:268–277PubMedCrossRef Kristensen DB, Kawada N, Imamura K et al (2000) Proteome analysis of rat hepatic stellate cells. Hepatology 32:268–277PubMedCrossRef
17.
Zurück zum Zitat Liu C, Gaca MD, Swenson ES et al (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells: constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 278:11721–11728PubMedCrossRef Liu C, Gaca MD, Swenson ES et al (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells: constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 278:11721–11728PubMedCrossRef
18.
Zurück zum Zitat Lu L, McCaslin D, Starzl TE et al (1995) Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539–1545PubMedCrossRef Lu L, McCaslin D, Starzl TE et al (1995) Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539–1545PubMedCrossRef
19.
Zurück zum Zitat Matzinger P (1991) The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185–192PubMedCrossRef Matzinger P (1991) The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185–192PubMedCrossRef
20.
Zurück zum Zitat Hatfield P, Merrick AE, West E et al (2008) Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy. J Immunother 31:620–632PubMedCrossRef Hatfield P, Merrick AE, West E et al (2008) Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy. J Immunother 31:620–632PubMedCrossRef
21.
Zurück zum Zitat Curiel TJ, Wei S, Dong H et al (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9:562–567PubMedCrossRef Curiel TJ, Wei S, Dong H et al (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9:562–567PubMedCrossRef
22.
Zurück zum Zitat Maher JJ (2001) Interactions between hepatic stellate cells and the immune system. Semin Liver Dis 21:417–426PubMedCrossRef Maher JJ (2001) Interactions between hepatic stellate cells and the immune system. Semin Liver Dis 21:417–426PubMedCrossRef
23.
Zurück zum Zitat Uemura T, Gandhi CR (2001) Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent. Br J Pharmacol 133:1125–1133PubMedCrossRef Uemura T, Gandhi CR (2001) Inhibition of DNA synthesis in cultured hepatocytes by endotoxin-conditioned medium of activated stellate cells is transforming growth factor-beta and nitric oxide-independent. Br J Pharmacol 133:1125–1133PubMedCrossRef
24.
Zurück zum Zitat Kalinski P (2001) Dendritic cell-related immunoregulation: signals and mediators. In: Lotze MT, Thomson AW (eds) Dendritic cells, 2nd edn. Academic Press, London, pp 62–66 Kalinski P (2001) Dendritic cell-related immunoregulation: signals and mediators. In: Lotze MT, Thomson AW (eds) Dendritic cells, 2nd edn. Academic Press, London, pp 62–66
25.
Zurück zum Zitat Wang SC, Ohata M, Schrum L et al (1998) Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273:302–308PubMedCrossRef Wang SC, Ohata M, Schrum L et al (1998) Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273:302–308PubMedCrossRef
26.
Zurück zum Zitat Thompson KC, Trowern A, Fowell A et al (1998) Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro. Hepatology 28:1518–1524PubMedCrossRef Thompson KC, Trowern A, Fowell A et al (1998) Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro. Hepatology 28:1518–1524PubMedCrossRef
27.
Zurück zum Zitat Savage CO, Hughes CC, Pepinsky RB et al (1991) Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. Cell Immunol 137:150–163PubMedCrossRef Savage CO, Hughes CC, Pepinsky RB et al (1991) Endothelial cell lymphocyte function-associated antigen-3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. Cell Immunol 137:150–163PubMedCrossRef
28.
Zurück zum Zitat Dong H, Zhu G, Tamada K, Chen L (1999) B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5:1365–1369PubMedCrossRef Dong H, Zhu G, Tamada K, Chen L (1999) B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5:1365–1369PubMedCrossRef
29.
Zurück zum Zitat Freeman GJ, Long AJ, Iwai Y et al (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027–1034PubMedCrossRef Freeman GJ, Long AJ, Iwai Y et al (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192:1027–1034PubMedCrossRef
30.
Zurück zum Zitat Carter L, Fouser LA, Jussif J et al (2002) PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32:634–643PubMedCrossRef Carter L, Fouser LA, Jussif J et al (2002) PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32:634–643PubMedCrossRef
31.
Zurück zum Zitat Agata Y, Kawasaki A, Nishimura H et al (1996) Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8:765–772PubMedCrossRef Agata Y, Kawasaki A, Nishimura H et al (1996) Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8:765–772PubMedCrossRef
32.
Zurück zum Zitat Larmonier N, Cathelin D, Larmonier C et al (2007) The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Exp Cell Res 313:2345–2355PubMedCrossRef Larmonier N, Cathelin D, Larmonier C et al (2007) The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Exp Cell Res 313:2345–2355PubMedCrossRef
33.
Zurück zum Zitat Viñas O, Bataller R, Sancho-Bru P et al (2003) Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 38:919–929PubMed Viñas O, Bataller R, Sancho-Bru P et al (2003) Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 38:919–929PubMed
34.
Zurück zum Zitat Winau F, Hegasy G, Weiskirchen R et al (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26:117–129PubMedCrossRef Winau F, Hegasy G, Weiskirchen R et al (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26:117–129PubMedCrossRef
35.
Zurück zum Zitat Faouzi S, Lepreux S, Bedin C et al (1999) Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest 79:485–493PubMed Faouzi S, Lepreux S, Bedin C et al (1999) Activation of cultured rat hepatic stellate cells by tumoral hepatocytes. Lab Invest 79:485–493PubMed
36.
Zurück zum Zitat Kobayashi S, Seki S, Kawada N et al (2003) Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells. Cell Tissue Res 311:353–364PubMed Kobayashi S, Seki S, Kawada N et al (2003) Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells. Cell Tissue Res 311:353–364PubMed
37.
Zurück zum Zitat Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793–800PubMed Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793–800PubMed
38.
Zurück zum Zitat Dong H, Gefeng Z, Tamada K et al (2004) B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes. Immunity 20:327–336PubMedCrossRef Dong H, Gefeng Z, Tamada K et al (2004) B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes. Immunity 20:327–336PubMedCrossRef
39.
Zurück zum Zitat Kanai T, Totsuka T, Uraushihara K et al (2003) Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 171:4156–4163PubMed Kanai T, Totsuka T, Uraushihara K et al (2003) Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 171:4156–4163PubMed
40.
Zurück zum Zitat Binker MG, Binker-Cosen AA, Gaisano HY et al (2011) TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2. Biochem Biophys Res Commun 405:140–145PubMedCrossRef Binker MG, Binker-Cosen AA, Gaisano HY et al (2011) TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2. Biochem Biophys Res Commun 405:140–145PubMedCrossRef
41.
Zurück zum Zitat Kim BC, Kim HT, Mamura M et al (2002) Tumor necrosis factor induces apoptosis in hepatoma cells by increasing Ca(2+) release from the endoplasmic reticulum and suppressing Bcl-2 expression. J Biol Chem 277:31381–31389PubMedCrossRef Kim BC, Kim HT, Mamura M et al (2002) Tumor necrosis factor induces apoptosis in hepatoma cells by increasing Ca(2+) release from the endoplasmic reticulum and suppressing Bcl-2 expression. J Biol Chem 277:31381–31389PubMedCrossRef
42.
Zurück zum Zitat Kinter AL, Godbout EJ, McNally JP, Sereti I et al (2008) The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 181:6738–6746PubMed Kinter AL, Godbout EJ, McNally JP, Sereti I et al (2008) The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 181:6738–6746PubMed
Metadaten
Titel
Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma
verfasst von
Yunhong Xia
Rongxin Chen
Sheng-Long Ye
Ruixia Sun
Jun Chen
Yan Zhao
Publikationsdatum
01.10.2011
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 7/2011
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-011-9399-3

Weitere Artikel der Ausgabe 7/2011

Clinical & Experimental Metastasis 7/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.